Citation Tools

Download PDFPDF
181
DOES JCV ANTIBODY POSITIVITY ENCOURAGE CESSATION OF NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS?

Download to a citation manager

Cite this article as:
Lonergan R, Kinsella K, Kelly S, et al
DOES JCV ANTIBODY POSITIVITY ENCOURAGE CESSATION OF NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS?